REQUEST A DEMO
Total
USD $0.00
Search more companies

Endoviewmed CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Other Scientific and Technical Consulting Services
Full name: Endoviewmed CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Endoviewmed CIA Ltda is an enterprise in Ecuador, with the main office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Endoviewmed CIA Ltda was incorporated on September 04, 2014. 22 (2023) employees currently work for Endoviewmed CIA Ltda. In its most recent financial highlights, the company reported a net sales revenue drop of 3.58% in 2023. A growth of 0.98% was recorded in its total assets. The net profit margin of Endoviewmed CIA Ltda increased by 2.01% in 2023.

Headquarters
Av. 6 de Diciembre N24417, Edificio Novus Bldg. , Floor 303
Quito; Pichincha;

Contact Details: Purchase the Endoviewmed CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Endoviewmed CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Endoviewmed CIA Ltda report to view the information.
Registered Capital:
Purchase the Endoviewmed CIA Ltda report to view the information.
Incorporation Date:
September 04, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Endoviewmed CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-3.58%
Total operating revenue
-4.42%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
55.47%
Total assets
0.98%
Total equity
52.63%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
2.01%
Return on Equity (ROE)
0.25%
Debt to Equity Ratio
-110.11%
Quick Ratio
0.15%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?